Free Trial

Medexus Pharmaceuticals (MDP) News Today

Medexus Pharmaceuticals logo
C$4.29 -0.01 (-0.23%)
As of 03:58 PM Eastern
Medexus Pharmaceuticals Inc. stock logo
FY2025 Earnings Estimate for TSE:MDP Issued By Stifel Canada
Medexus Pharmaceuticals Inc. (TSE:MDP - Free Report) - Analysts at Stifel Canada lifted their FY2025 earnings per share (EPS) estimates for shares of Medexus Pharmaceuticals in a research report issued to clients and investors on Monday, January 13th. Stifel Canada analyst J. Keywood now anticipa
Medexus Pharmaceuticals Inc. stock logo
Medexus Pharmaceuticals (TSE:MDP) Reaches New 52-Week High on Analyst Upgrade
Medexus Pharmaceuticals (TSE:MDP) Sets New 12-Month High Following Analyst Upgrade
Medexus Pharmaceuticals Inc. stock logo
Medexus Pharmaceuticals (TSE:MDP) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says
Stifel Nicolaus upped their price target on shares of Medexus Pharmaceuticals from C$4.15 to C$4.50 in a report on Tuesday.
Q3 Earnings Forecast for TSE:MDP Issued By Raymond James
Medexus Pharmaceuticals (TSE:MDP) Upgraded at Raymond James
Medexus Pharmaceuticals Inc. stock logo
Raymond James Issues Negative Forecast for TSE:MDP Earnings
Medexus Pharmaceuticals Inc. (TSE:MDP - Free Report) - Analysts at Raymond James reduced their Q3 2025 earnings per share estimates for Medexus Pharmaceuticals in a report released on Tuesday, January 7th. Raymond James analyst M. Freeman now anticipates that the company will post earnings of ($0
Medexus Pharmaceuticals Inc. stock logo
Medexus Pharmaceuticals (TSE:MDP) Hits New 52-Week High - What's Next?
Medexus Pharmaceuticals (TSE:MDP) Reaches New 12-Month High - Time to Buy?
Medexus Pharmaceuticals Inc. stock logo
Raymond James Has Pessimistic Outlook of TSE:MDP Q3 Earnings
Medexus Pharmaceuticals Inc. (TSE:MDP - Free Report) - Research analysts at Raymond James decreased their Q3 2026 earnings per share estimates for shares of Medexus Pharmaceuticals in a research report issued on Tuesday, January 7th. Raymond James analyst M. Freeman now expects that the company w
Medexus Pharmaceuticals Inc. stock logo
Medexus Pharmaceuticals (TSE:MDP) Stock Rating Upgraded by Raymond James
Raymond James upgraded Medexus Pharmaceuticals from an "outperform" rating to a "strong-buy" rating and set a C$4.00 target price on the stock in a research note on Wednesday.
Medexus Pharmaceuticals Inc. stock logo
Medexus Pharmaceuticals (TSE:MDP) Reaches New 1-Year High - Here's What Happened
Medexus Pharmaceuticals (TSE:MDP) Sets New 52-Week High - Time to Buy?
Medexus Pharmaceuticals Inc. stock logo
Medexus Pharmaceuticals (TSE:MDP) Reaches New 1-Year High - Should You Buy?
Medexus Pharmaceuticals (TSE:MDP) Hits New 52-Week High - Here's What Happened
Medexus Pharmaceuticals Inc. stock logo
Medexus Pharmaceuticals Inc. (TSE:MDP) Receives Average Rating of "Buy" from Brokerages
Shares of Medexus Pharmaceuticals Inc. (TSE:MDP - Get Free Report) have been given an average recommendation of "Buy" by the five analysts that are currently covering the company, MarketBeat.com reports. Three analysts have rated the stock with a buy rating and two have given a strong buy rating to
Medexus Pharmaceuticals Inc. stock logo
Equities Analysts Issue Forecasts for TSE:MDP Q3 Earnings
Medexus Pharmaceuticals Inc. (TSE:MDP - Free Report) - Raymond James issued their Q3 2025 EPS estimates for shares of Medexus Pharmaceuticals in a research report issued on Tuesday, November 19th. Raymond James analyst M. Freeman forecasts that the company will post earnings of $0.01 per share fo
Medexus Pharmaceuticals Inc. stock logo
Raymond James Predicts TSE:MDP FY2029 Earnings
Medexus Pharmaceuticals Inc. (TSE:MDP - Free Report) - Equities researchers at Raymond James issued their FY2029 earnings per share estimates for shares of Medexus Pharmaceuticals in a report released on Tuesday, November 19th. Raymond James analyst R. Sarugaser forecasts that the company will po
Medexus Pharmaceuticals Inc. stock logo
Leede Financial Issues Negative Outlook for TSE:MDP Earnings
Medexus Pharmaceuticals Inc. (TSE:MDP - Free Report) - Stock analysts at Leede Financial lowered their FY2026 earnings estimates for Medexus Pharmaceuticals in a report issued on Friday, November 8th. Leede Financial analyst D. Loe now anticipates that the company will post earnings per share of
Medexus Pharmaceuticals Inc. stock logo
Medexus Pharmaceuticals (MDP) Set to Announce Earnings on Thursday
Medexus Pharmaceuticals (TSE:MDP) will be releasing earnings after the market closes on Thursday, November 7, Zacks reports.
Medexus Pharmaceuticals Inc. stock logo
Medexus Pharmaceuticals (TSE:MDP) Trading Up 1.6% - Should You Buy?
Medexus Pharmaceuticals (TSE:MDP) Trading 1.6% Higher - Here's Why
Medexus Pharmaceuticals Inc. stock logo
Analysts Issue Forecasts for Medexus Pharmaceuticals Inc.'s Q2 2025 Earnings (TSE:MDP)
Medexus Pharmaceuticals Inc. (TSE:MDP - Free Report) - Analysts at Leede Financial issued their Q2 2025 earnings estimates for shares of Medexus Pharmaceuticals in a research note issued to investors on Monday, September 30th. Leede Financial analyst D. Loe forecasts that the company will post ea
Medexus Pharmaceuticals Inc. stock logo
Leede Financial Reiterates "C$8.25" Price Target for Medexus Pharmaceuticals (TSE:MDP)
Leede Financial set a C$8.25 price objective on shares of Medexus Pharmaceuticals and gave the company a "speculative buy" rating in a research note on Monday.
Medexus Pharmaceuticals Inc. stock logo
Ventum Cap Mkts Equities Analysts Reduce Earnings Estimates for Medexus Pharmaceuticals Inc. (TSE:MDP)
Medexus Pharmaceuticals Inc. (TSE:MDP - Free Report) - Ventum Cap Mkts lowered their FY2025 earnings per share estimates for Medexus Pharmaceuticals in a research note issued on Monday, September 16th. Ventum Cap Mkts analyst S. Quenneville now expects that the company will earn $0.24 per share f
Medexus Pharmaceuticals Inc. stock logo
Medexus Pharmaceuticals (TSE:MDP) Stock Price Down 19.4%
Medexus Pharmaceuticals (TSE:MDP) Trading Down 19.4%
Medexus Pharmaceuticals Inc. stock logo
Medexus Pharmaceuticals (TSE:MDP) Shares Up 6.6%
Medexus Pharmaceuticals (TSE:MDP) Trading Up 6.6%
Medexus Pharmaceuticals Inc. stock logo
Q3 2025 EPS Estimates for Medexus Pharmaceuticals Inc. (TSE:MDP) Lowered by Analyst
Medexus Pharmaceuticals Inc. (TSE:MDP - Free Report) - Research analysts at Bloom Burton dropped their Q3 2025 earnings per share (EPS) estimates for shares of Medexus Pharmaceuticals in a research note issued to investors on Friday, August 9th. Bloom Burton analyst D. Martin now expects that the
Medexus Pharmaceuticals Inc. stock logo
Medexus Pharmaceuticals (MDP) Scheduled to Post Earnings on Wednesday
Medexus Pharmaceuticals (TSE:MDP) will be releasing earnings after the market closes on Wednesday, August 7, Zacks reports.
Medexus Pharmaceuticals Inc (MDP)
Medexus Pharmaceuticals Inc (P731.BE)
Get Medexus Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for MDP and its competitors with MarketBeat's FREE daily newsletter.

MDP Media Mentions By Week

MDP Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MDP
News Sentiment

0.89

0.44

Average
Medical
News Sentiment

MDP News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MDP Articles
This Week

9

0

MDP Articles
Average Week

Get Medexus Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for MDP and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (TSE:MDP) was last updated on 1/20/2025 by MarketBeat.com Staff
From Our Partners